Cypherpunk Technologies, Inc. (CYPH)
3.045
-0.22
(-6.60%)
USD |
NASDAQ |
Oct 07, 16:00
3.03
-0.02
(-0.49%)
After-Hours: 20:00
Cypherpunk Technologies Enterprise Value : 343.73M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 343.73M |
| October 05, 2026 | 334.03M |
| October 02, 2026 | 318.94M |
| October 01, 2026 | 307.09M |
| September 30, 2026 | 351.27M |
| September 29, 2026 | 340.49M |
| September 28, 2026 | 349.11M |
| September 25, 2026 | 436.40M |
| September 24, 2026 | 432.09M |
| September 23, 2026 | 381.44M |
| September 22, 2026 | 394.38M |
| September 21, 2026 | 358.81M |
| September 18, 2026 | 380.37M |
| September 17, 2026 | 323.25M |
| September 16, 2026 | 255.36M |
| September 15, 2026 | 231.65M |
| September 14, 2026 | 270.45M |
| September 11, 2026 | 236.50M |
| September 10, 2026 | 229.50M |
| September 09, 2026 | 256.44M |
| September 08, 2026 | 275.83M |
| September 04, 2026 | 253.20M |
| September 03, 2026 | 237.04M |
| September 02, 2026 | 173.46M |
| September 01, 2026 | 176.69M |
| Date | Value |
|---|---|
| August 31, 2026 | 189.08M |
| August 28, 2026 | 176.69M |
| August 27, 2026 | 196.09M |
| August 26, 2026 | 168.07M |
| August 25, 2026 | 169.15M |
| August 24, 2026 | 173.46M |
| August 21, 2026 | 145.44M |
| August 20, 2026 | 120.65M |
| August 19, 2026 | 107.72M |
| August 18, 2026 | 79.21M |
| August 17, 2026 | 68.42M |
| August 14, 2026 | 61.81M |
| August 13, 2026 | 62.25M |
| August 12, 2026 | 63.31M |
| August 11, 2026 | 65.69M |
| August 10, 2026 | 65.66M |
| August 07, 2026 | 66.62M |
| August 06, 2026 | 65.03M |
| August 05, 2026 | 71.41M |
| August 04, 2026 | 66.77M |
| August 03, 2026 | 61.04M |
| July 31, 2026 | 56.06M |
| July 30, 2026 | 59.83M |
| July 29, 2026 | 57.17M |
| July 28, 2026 | 58.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Indaptus Therapeutics, Inc. | 333.54M |
| ACADIA Pharmaceuticals, Inc. | 2.515B |
| Alnylam Pharmaceuticals, Inc. | 29.63B |
| Savara, Inc. | 812.48M |
| Vericel Corp. | 1.982B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 39.39M |
| Total Expenses (Quarterly) | -39.39M |
| EPS Diluted (Quarterly) | 0.1812 |
| Earnings Yield | 18.57% |
| Normalized Earnings Yield | -2.289 |